The colorectal cancer cell line Caco2 has previously been demonstrated to contain a subpopulation of CSCs with tumor initiating capacity characterized by expression of the CD133 and CD44 surface markers when grown in serum containing media [44]. The gene discussed is CD44; the disease is neoplasm.